FDA grant to fund a center researching complex generics, fostering collaboration between the FDA, industry, academia, and the public to improve access to generic drugs.
FDA funds research on complex generics to expand access to safe, effective generic medicines and reduce drug shortages through a more competitive, multi-sourced U.S. market.
FDA grant supports collaborative projects to advance drug development, manufacturing, and regulatory science, focusing on safety, efficacy, and innovation.
Repurposing Generic (ReGen) Drugs Evidence Package Challenge supports individuals, teams, and entities developing evidence for new generic drug uses in high-cost conditions to advance access to affordable treatments.
FDA grant seeks research to reduce nitrosamine impurities in drugs, ensuring public safety and continued access to needed medications, with a plan for sustained research.
This grant seeks to develop AI/ML models using real-world data to monitor clinical outcomes when patients switch between complex generics and brand-name drugs.